Dr. Reddy's Laboratories (RDY) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Dr. Reddy's Laboratories Revenue Highlights

Latest Revenue (Y)

$279.16B

Main Geography (Y)

UNITED STATES

Dr. Reddy's Laboratories Revenue by Period

Dr. Reddy's Laboratories Revenue by Year

Date	Revenue	Change
2024-03-31	$279.16B	13.54%
2023-03-31	$245.88B	14.69%
2022-03-31	$214.39B	13.00%
2021-03-31	$189.72B	8.66%
2020-03-31	$174.60B	13.49%
2019-03-31	$153.85B	8.32%
2018-03-31	$142.03B	0.87%
2017-03-31	$140.81B	-8.98%
2016-03-31	$154.71B	4.40%
2015-03-31	$148.19B	12.12%
2014-03-31	$132.17B	13.68%
2013-03-31	$116.27B	20.19%
2012-03-31	$96.74B	29.51%
2011-03-31	$74.69B	6.28%
2010-03-31	$70.28B	1.20%
2009-03-31	$69.44B	38.87%
2008-03-31	$50.01B	-23.36%
2007-03-31	$65.25B	168.19%
2006-03-31	$24.33B	24.95%
2005-03-31	$19.47B	-3.24%
2004-03-31	$20.12B	11.69%
2003-03-31	$18.02B	8.51%
2002-03-31	$16.60B	51.85%
2001-03-31	$10.94B	-

Dr. Reddy's Laboratories generated $279.16B in revenue during NA 2024, up 13.54% compared to the previous quarter, and up 181.45% compared to the same period a year ago.

Dr. Reddy's Laboratories Revenue by Quarter

Date	Revenue	Change
2024-03-31	-	-100.00%
2023-12-31	$72.15B	4.86%
2023-09-30	$68.80B	2.10%
2023-06-30	$67.38B	7.01%
2023-03-31	$62.97B	-6.99%
2022-12-31	$67.70B	7.36%
2022-09-30	$63.06B	20.91%
2022-06-30	$52.15B	-4.07%
2022-03-31	$54.37B	2.20%
2021-12-31	$53.20B	-7.70%
2021-09-30	$57.63B	17.15%
2021-06-30	$49.19B	4.04%
2021-03-31	$47.28B	-4.08%
2020-12-31	$49.30B	0.67%
2020-09-30	$48.97B	10.85%
2020-06-30	$44.17B	-0.32%
2020-03-31	$44.32B	1.09%
2019-12-31	$43.84B	-8.69%
2019-09-30	$48.01B	24.91%
2019-06-30	$38.44B	-4.31%
2019-03-31	$40.17B	4.33%
2018-12-31	$38.50B	1.37%
2018-09-30	$37.98B	2.07%
2018-06-30	$37.21B	5.26%
2018-03-31	$35.35B	-7.12%
2017-12-31	$38.06B	7.33%
2017-09-30	$35.46B	6.94%
2017-06-30	$33.16B	-6.70%
2017-03-31	$35.54B	-4.11%
2016-12-31	$37.06B	3.37%
2016-09-30	$35.86B	10.86%
2016-06-30	$32.34B	-13.89%
2016-03-31	$37.56B	-5.34%
2015-12-31	$39.68B	-0.53%
2015-09-30	$39.89B	6.15%
2015-06-30	$37.58B	-2.91%
2015-03-31	$38.70B	0.71%
2014-12-31	$38.43B	7.11%
2014-09-30	$35.88B	2.00%
2014-06-30	$35.17B	1.05%
2014-03-31	$34.81B	-1.50%
2013-12-31	$35.34B	5.25%
2013-09-30	$33.58B	18.02%
2013-06-30	$28.45B	-14.82%
2013-03-31	$33.40B	16.58%
2012-12-31	$28.65B	-0.55%
2012-09-30	$28.81B	13.39%
2012-06-30	$25.41B	28.42%
2012-03-31	$19.78B	-28.56%
2011-12-31	$27.69B	22.11%
2011-09-30	$22.68B	14.63%
2011-06-30	$19.78B	-1.93%
2011-03-31	$20.17B	6.26%
2010-12-31	$18.98B	1.50%
2010-09-30	$18.70B	11.13%
2010-06-30	$16.83B	2.48%
2010-03-31	$16.42B	-5.05%
2009-12-31	$17.30B	-5.84%
2009-09-30	$18.37B	0.98%
2009-06-30	$18.19B	-8.37%
2009-03-31	$19.85B	7.88%
2008-12-31	$18.40B	13.93%
2008-09-30	$16.15B	7.40%
2008-06-30	$15.04B	13.76%
2008-03-31	$13.22B	-

Dr. Reddy's Laboratories generated - in revenue during Q4 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Dr. Reddy's Laboratories Revenue Breakdown

Dr. Reddy's Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Russia Country	$22.30B	$21.23B	$20.88B	$15.82B	$16.90B
UNITED STATES	$135.56B	-	-	-	-
Others Countries Country	$72.83B	$67.47B	$68.96B	$60.95B	$49.58B
India Country	$48.47B	$50.50B	$43.99B	$36.25B	$32.09B

Dr. Reddy's Laboratories's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (48.56%), Others Countries Country (26.09%), India Country (17.36%), and Russia Country (7.99%).

Dr. Reddy's Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
RDY	Dr. Reddy's Laboratories	$279.16B	-
ALKS	Alkermes	$1.66B	$378.14M
PBH	Prestige Consumer Healthcare	$1.13B	$283.55M
PAHC	Phibro Animal Health	$977.89M	$273.16M
EVO	Evotec SE	$781.43M	$208.73M
PCRX	Pacira BioSciences	$674.98M	$168.57M
SUPN	Supernus Pharmaceuticals	$607.52M	$175.69M
COLL	Collegium Pharmaceutical	$566.77M	$159.30M
ANIP	ANI Pharmaceuticals	$486.82M	$148.33M
ITCI	Intra-Cellular Therapies	$462.18M	$175.38M
EGRX	Eagle Pharmaceuticals	$316.61M	$64.65M
DCPH	Deciphera Pharmaceuticals	$163.36M	$45.00M
SSIC	Silver Spike Investment	$11.72M	$2.76B

RDY Revenue FAQ

What is Dr. Reddy's Laboratories’s yearly revenue?

Dr. Reddy's Laboratories's yearly revenue for 2024 was $279.16B, representing an increase of 13.54% compared to 2023. The company's yearly revenue for 2023 was $245.88B, representing an increase of 14.69% compared to 2022. RDY's yearly revenue for 2022 was $214.39B, representing an increase of 13.00% compared to 2021.

What is Dr. Reddy's Laboratories’s quarterly revenue?

Dr. Reddy's Laboratories's quarterly revenue for Q4 2024 was $0, a -100.00% decrease from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $72.15B, a 4.86% increase from the previous quarter (Q2 2024), and a 6.57% increase year-over-year (Q3 2023). RDY's quarterly revenue for Q2 2024 was $68.8B, a 2.10% increase from the previous quarter (Q1 2024), and a 9.11% increase year-over-year (Q2 2023).

What is Dr. Reddy's Laboratories’s revenue growth rate?

Dr. Reddy's Laboratories's revenue growth rate for the last 3 years (2022-2024) was 30.21%, and for the last 5 years (2020-2024) was 59.89%.